+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Rheumatoid Arthritis (RA) Therapy Area Report - Product Thumbnail Image

Rheumatoid Arthritis (RA) Therapy Area Report

  • Report
  • February 2022
  • 65 Pages
  • Global
From
South African Allergy Care Industry Landscape Report 2020 - Product Thumbnail Image

South African Allergy Care Industry Landscape Report 2020

  • Report
  • May 2020
  • 92 Pages
  • South Africa
From
From
AbbVie Hit Harder By EU Humira Biosimilars Than Projected - Product Thumbnail Image

AbbVie Hit Harder By EU Humira Biosimilars Than Projected

  • Newsletter
  • November 2024
  • 3 Pages
  • Europe
From
Novothyrox - API Insight, 2022 - Product Thumbnail Image

Novothyrox - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Bepanthene - API Insight, 2022 - Product Thumbnail Image

Bepanthene - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Colcrys - API Insight, 2022 - Product Thumbnail Image

Colcrys - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Xyzall - API Insight, 2022 - Product Thumbnail Image

Xyzall - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Telfast - API Insight, 2022 - Product Thumbnail Image

Telfast - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Graceptor - API Insight, 2022 - Product Thumbnail Image

Graceptor - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Protopic - API Insight, 2022 - Product Thumbnail Image

Protopic - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Prograf - API Insight, 2022 - Product Thumbnail Image

Prograf - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Rapamune - API Insight, 2022 - Product Thumbnail Image

Rapamune - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Veramyst - API Insight, 2022 - Product Thumbnail Image

Veramyst - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Talion - API Insight, 2022 - Product Thumbnail Image

Talion - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Takepron - API Insight, 2022 - Product Thumbnail Image

Takepron - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Acthar Gel - API Insight, 2022 - Product Thumbnail Image

Acthar Gel - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more